The report, issued Monday by researchers at the Fairbanks School of Public Health at IUPUI, is the latest commentary on Indiana’s poor report card on health care.
Indiana University Health’s new Schwarz Cancer Center is the latest addition to a crowded landscape of cancer centers and hospital oncology programs popping up around central Indiana.
Indianapolis-based Pet Wellness Clinics opened its first clinic in Fishers in 2005. The company became profitable a year later and has been in the black—and growing—ever since.
Republican leaders of the Indiana General Assembly and Gov. Eric Holcomb have made addressing high health care costs a top priority this year, but the bills proposed to do so are unlikely to have much direct impact.
The Indianapolis drugmaker quietly terminated a collaboration with NextCure Inc. after spending $40 million on an up-front fee and equity investment, and with little to show from the partnership.
A high-stakes suit this month by the federal government against Community Health Network is raising questions about when they are proper and when they cross the line.
After raking in record amounts of venture capital funding in 2017 and 2018, Indiana life science companies saw funding drop last year by double-digits, while the average deal amount dipped sharply as well.
Upscale, fast service, with lots of consumer touches: It’s a growing model for retail health care in Indiana and around the nation.
Dr. Anantha Shekhar, a nationally recognized health sciences researcher and entrepreneur, has played a major role in boosting research funding at IU, where he has worked since 1989 in numerous leadership roles.
A deal to build a new family center at Broad Ripple Park could be just the first of several privately funded projects considered by the park system.
U.S. health officials will begin cracking down on most flavored e-cigarettes that are popular with underage teenagers, but the policy will spare a significant portion of the multibillion-dollar vaping market aimed at adults.
The law approved by the Democratic-controlled Legislature and signed by Gov. J.B. Pritzker allows people 21 or older to possess of up to 30 grams of cannabis flower and up to 5 grams of cannabis concentrate.
Alimta is Lilly’s third-best-selling drug, with global sales of $2.1 billion last year. The court ruling stops a Canadian competitor from launching a generic version of the drug before its patent expires in 2022.
The year didn’t feature any hostile takeovers or huge disasters. But a lot of companies made big strides in 2019, including Eli Lilly and Co., Corteva and Elanco. And many rejoiced when Washington ended a 2.3% tax on thousands of medical devices.
CEO Gail Boudreaux’s recent comments at a health care summit dampened speculation that Anthem might create its own physician group, something the insurer tried unsuccessfully two decades ago.
Neuropsychiatric Hospitals LLC said it is developing a 64-bed hospital in Greenwood that will serve patients with complex medical and psychiatric condition.
Founded in 1983, the practice has 28 physicians and annual revenue of $35 million, and shows little sign of slowing.
Starting out in 2005 with just four sets of sunglass frames, the eyeglass company now offers five lines for men and women with more than 100 frame styles.
The retirement community operator had revenue of $51.4 million last year, up 4% from 2017, according to its Form 990 tax return.
Medistar Corp. of Texas has filed an application to build a 42,610-square-foot building at 795 North Emerson Avenue, a vacant and undeveloped site about a mile south of Franciscan Health Indianapolis.
